Literature DB >> 23277194

Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR).

Anna R Malik1, Malgorzata Urbanska, Matylda Macias, Agnieszka Skalecka, Jacek Jaworski.   

Abstract

Mammalian target of rapamycin (mTOR) is a serine-threonine kinase involved in almost every aspect of mammalian cell function. This kinase was initially believed to control protein translation in response to amino acids and trophic factors, and this function has become a canonical role for mTOR. However, mTOR can form two separate protein complexes (mTORCs). Recent advances clearly demonstrate that both mTORCs can respond to various stimuli and change myriad cellular processes. Therefore, our current view of the cellular roles of TORCs has rapidly expanded and cannot be fully explained without appreciating recent findings about the new modes of mTOR regulation and identification of non-canonical effectors of mTOR that contribute to transcription, cytoskeleton dynamics, and membrane trafficking. This review discusses the molecular details of these newly discovered non-canonical functions that allow mTORCs to control the cellular environment at multiple levels. This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23277194     DOI: 10.1016/j.bbapap.2012.12.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  Dysplasia and overgrowth: magnetic resonance imaging of pediatric brain abnormalities secondary to alterations in the mechanistic target of rapamycin pathway.

Authors:  Shai Shrot; Misun Hwang; Carl E Stafstrom; Thierry A G M Huisman; Bruno P Soares
Journal:  Neuroradiology       Date:  2017-12-26       Impact factor: 2.804

2.  Gad8 Protein Is Found in the Nucleus Where It Interacts with the MluI Cell Cycle Box-binding Factor (MBF) Transcriptional Complex to Regulate the Response to DNA Replication Stress.

Authors:  Adiel Cohen; Martin Kupiec; Ronit Weisman
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

3.  mTOR pathway as a potential target in a subset of human medulloblastoma.

Authors:  Tímea Pócza; Anna Sebestyén; Eszter Turányi; Tibor Krenács; Agnes Márk; Tamás Béla Sticz; Zsuzsanna Jakab; Péter Hauser
Journal:  Pathol Oncol Res       Date:  2014-04-16       Impact factor: 3.201

Review 4.  Defective phosphoinositide metabolism in autism.

Authors:  Christina Gross
Journal:  J Neurosci Res       Date:  2016-07-04       Impact factor: 4.164

5.  mTOR controls endoplasmic reticulum-Golgi apparatus trafficking of VSVg in specific cell types.

Authors:  Alicja Koscielny; Ewa Liszewska; Katarzyna Machnicka; Michalina Wezyk; Katarzyna Kotulska; Jacek Jaworski
Journal:  Cell Mol Biol Lett       Date:  2021-05-18       Impact factor: 5.787

6.  REDD2-mediated inhibition of mTOR promotes dendrite retraction induced by axonal injury.

Authors:  B Morquette; P Morquette; J Agostinone; E Feinstein; R A McKinney; A Kolta; A Di Polo
Journal:  Cell Death Differ       Date:  2014-09-26       Impact factor: 15.828

Review 7.  Where is mTOR and what is it doing there?

Authors:  Charles Betz; Michael N Hall
Journal:  J Cell Biol       Date:  2013-11-25       Impact factor: 10.539

Review 8.  Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.

Authors:  Henry Querfurth; Han-Kyu Lee
Journal:  Mol Neurodegener       Date:  2021-07-02       Impact factor: 14.195

9.  Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment.

Authors:  Matylda Macias; Magdalena Blazejczyk; Paulina Kazmierska; Bartosz Caban; Agnieszka Skalecka; Bartosz Tarkowski; Anna Rodo; Jan Konopacki; Jacek Jaworski
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

10.  Tuberous sclerosis complex neuropathology requires glutamate-cysteine ligase.

Authors:  Anna R Malik; Ewa Liszewska; Agnieszka Skalecka; Malgorzata Urbanska; Anand M Iyer; Lukasz J Swiech; Malgorzata Perycz; Kamil Parobczak; Patrycja Pietruszka; Malgorzata M Zarebska; Matylda Macias; Katarzyna Kotulska; Julita Borkowska; Wieslawa Grajkowska; Magdalena E Tyburczy; Sergiusz Jozwiak; David J Kwiatkowski; Eleonora Aronica; Jacek Jaworski
Journal:  Acta Neuropathol Commun       Date:  2015-07-30       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.